Outsourcing Communities
Influence the Decisions Behind External Development and Manufacturing
Connect with pharma and biopharma leaders responsible for outsourcing strategy, external manufacturing, CMC, quality, procurement, and supply chain through trusted content, market intelligence, peer exchange, recognition, and in-person events.
The Outsourcing Audience Advantage
Engage the People Shaping Outsourcing Partner Decisions
Outsourcing decisions involve long timelines, complex buying groups, technical evaluation, and significant operational risk. Our communities connect companies with the biopharma professionals evaluating capabilities, selecting outsourcing partners, managing relationships, and protecting program continuity.
Partner Evaluation & Selection
Leaders assessing capabilities, capacity, quality, regulatory readiness, fit, and long-term partnership potential.
Development & Tech Transfer
Teams planning formulation, process development, scale-up, transfer, validation, and clinical-to-commercial transitions.
Quality, Supply & Risk
Professionals managing quality agreements, audits, compliance, capacity, supply continuity, communication, and execution risk.
Network Strategy & Resilience
Senior leaders shaping external networks, procurement strategy, geographic diversification, and long-term manufacturing resilience.
OUTSOURCING COMMUNITIES
Where Outsourcing Leaders Go for Trusted Insight
Explore the communities outsourcing decision-makers and influencers use to evaluate capabilities, manage partnerships, reduce risk, and make more informed external development and manufacturing decisions.
The dedicated LSC community for pharmaceutical professionals responsible for external development, manufacturing, fill/finish, and strategic outsourcing relationships.
These professionals influence outsourcing partner selection, tech transfer, quality oversight, supply continuity, and the external relationships that determine whether development and manufacturing programs advance successfully.
Relevant Reader Roles and Titles
- Outsourcing Strategy
- External Manufacturing
- CMC
- Manufacturing
- Fill/Finish Operations
- Drug Product Manufacturing
- Quality
- Regulatory Affairs
- Supply Chain
- Procurement
- Alliance Management
- Executive Leadership
Sample Reader Organizations
- Global pharmaceutical companies managing external manufacturing networks
- Emerging and midsize biotech companies preparing to outsource
- Virtual biopharma organizations relying on development and manufacturing partners
- Pharma and biotech teams managing multiple CDMO and fill/finish relationships
High-Interest Topics
- CDMO Selection
- Outsourcing Strategy
- External Manufacturing
- Fill/Finish Capacity
- Tech Transfer
- Drug Product Strategy
- Quality Agreements
- Partner Audits
- Regulatory Oversight
- Supply Continuity
Ways to Engage This Audience
Content and Thought Leadership
Articles, white papers, case studies, and sponsored content focused on outsourcing strategy, partner selection, tech transfer, quality, capacity, and supply continuity.
Video and Webinars
Webcasts, video interviews, and STREAM programs that help biopharma teams explore outsourcing challenges, capabilities, and partnership approaches.
Targeted Audience Programs
ABM360, interest-based programs, custom newsletters, and newsletter visibility aligned to priority roles, service categories, and target accounts.
Outsourcing Experiences
Outsourced Pharma Live and the Outsourced Pharma Capabilities Update create focused opportunities for education, capability visibility, and audience interaction.
Additional Audience Reach
Expand into related scientific, technical, operational, and executive audiences involved in defining requirements, evaluating options, and managing external partners.
A specialized community for professionals advancing biologics process development, scale-up, technology transfer, manufacturing, and facility operations.
Process development, MSAT, CMC, engineering, and manufacturing teams often help define the technical requirements used to evaluate external development and manufacturing partners.
Relevant Reader Roles and Titles
- Process Development
- MSAT
- CMC
- Biomanufacturing
- Manufacturing Sciences
- Tech Transfer
- Engineering
- Quality
- Validation
- Supply Chain
- Facility Operations
- Scientific Leadership
Sample Reader Organizations
- Biologics developers preparing for scale-up or transfer
- Pharma companies managing internal and external manufacturing networks
- Emerging biotechs evaluating process development and manufacturing support
- Organizations commercializing complex biologics
High-Interest Topics
- Process Development
- Scale-Up
- Tech Transfer
- Upstream Processing
- Downstream Processing
- Single-Use Systems
- Process Intensification
- Facility Design
- Validation
- Manufacturing Strategy
Ways to Engage This Audience
Content and Thought Leadership
Technical articles, white papers, case studies, and sponsored content addressing process development, scale-up, manufacturing, analytics, and technology transfer.
Video and Webinars
Webcasts, video interviews, and STREAM programs that help scientific and technical teams evaluate complex technologies and manufacturing approaches.
Targeted Audience Programs
ABM360, interest-based programs, custom newsletters, and newsletter visibility focused on priority technical roles, modalities, and target accounts.
Live and Virtual Experiences
Bioprocess Online Live and Bio-Expo Live connect company expertise with technical education and solution discovery.
A trusted community for professionals working across pharmaceutical manufacturing, processing, facilities, packaging, quality, validation, automation, and operational execution.
Manufacturing, engineering, quality, and validation teams influence service requirements, technology choices, facility decisions, and the operational standards expected of external partners.
Relevant Reader Roles and Titles
- Manufacturing
- Operations
- Engineering
- Facilities
- Quality
- Validation
- Packaging
- Automation
- Process Development
- Regulatory Affairs
- Maintenance
- Technical Operations
Sample Reader Organizations
- Pharmaceutical manufacturers managing internal and external capacity
- Drug product organizations evaluating equipment and service partners
- Facilities modernizing manufacturing and packaging operations
- Quality and validation teams overseeing compliant execution
High-Interest Topics
- Pharma Manufacturing
- Aseptic Processing
- Packaging
- Facility Design
- Automation
- Validation
- Quality Systems
- Serialization
- Process Equipment
- Operational Excellence
Ways to Engage This Audience
Content and Thought Leadership
Articles, white papers, case studies, and sponsored content focused on manufacturing, facilities, engineering, quality, validation, packaging, and operations.
Video and Webinars
Webcasts, video interviews, and STREAM programs that demonstrate technologies and explain manufacturing and operational approaches in greater depth.
Targeted Audience Programs
ABM360, interest-based programs, and custom newsletters aligned to manufacturing, engineering, quality, facilities, and operations audiences.
Live and Virtual Experiences
Pharmaceutical Online Live and Virtual Pharma Expo support technical education, equipment discovery, and focused audience engagement.
A focused community for professionals advancing cell, gene, and other complex modalities through development, manufacturing, quality, regulatory, clinical, and commercial stages.
Advanced therapy developers face specialized capacity, process, analytical, logistics, and regulatory challenges that make external partner expertise especially important.
Relevant Reader Roles and Titles
- Cell Therapy Development
- Gene Therapy Development
- Process Development
- MSAT
- CMC
- Manufacturing
- Quality
- Regulatory Affairs
- Clinical Operations
- Supply Chain
- Commercial Leadership
Sample Reader Organizations
- Cell and gene therapy developers
- Emerging advanced therapy biotechs
- Pharma organizations expanding into complex modalities
- Teams evaluating specialized development, testing, manufacturing, and logistics partners
High-Interest Topics
- Cell Therapy
- Gene Therapy
- Viral Vectors
- Manufacturing
- Process Development
- Analytical Development
- Quality
- Regulatory Strategy
- Cold Chain
- Commercialization
Ways to Engage This Audience
Content and Thought Leadership
Articles, white papers, case studies, and sponsored content focused on advanced therapy development, manufacturing, analytics, quality, logistics, and regulatory strategy.
Video and Webinars
Webcasts, video interviews, and STREAM programs that help specialized teams evaluate technologies, platforms, and external capabilities.
Targeted Audience Programs
ABM360, interest-based programs, and custom newsletters focused on priority cell and gene therapy roles, organizations, and target accounts.
Live Editorial Programming
Cell & Gene Live connects company expertise with editor-led discussion of the challenges shaping advanced therapy development and manufacturing.
A community for scientists, research leaders, and technology teams working across target identification, assay development, screening, preclinical research, and early development.
Discovery and preclinical teams influence the selection of CROs, research platforms, specialized assays, analytical services, and external expertise long before a molecule reaches manufacturing.
Relevant Reader Roles and Titles
- Discovery Research
- Preclinical R&D
- Assay Development
- Screening
- Translational Science
- Biology
- Chemistry
- DMPK
- Toxicology
- Lab Operations
- Research Leadership
Sample Reader Organizations
- Discovery-stage biotech companies
- Pharmaceutical R&D organizations
- Translational and preclinical research groups
- Teams outsourcing assays, screening, models, analytics, and specialized research
High-Interest Topics
- Target Identification
- Assay Development
- Screening
- AI & Machine Learning
- Preclinical Models
- DMPK
- Toxicology
- Biomarkers
- Translational Research
- Research Outsourcing
Ways to Engage This Audience
Content and Thought Leadership
Technical articles, white papers, application notes, case studies, and sponsored content focused on targets, assays, screening, models, data, and preclinical research.
Video and Webinars
Webcasts and video interviews that explain scientific platforms, methods, and technologies used across early discovery and preclinical development.
Targeted Audience Programs
ABM360, interest-based programs, and custom newsletters focused on discovery scientists, research leaders, and target accounts.
A focused community for professionals advancing formulation, drug product development, delivery technologies, combination products, and patient-centered administration.
Formulation, device, CMC, and product development teams help determine which external specialists, technologies, and manufacturing partners are needed to bring a drug product to patients.
Relevant Reader Roles and Titles
- Formulation Development
- Drug Product Development
- Device Development
- CMC
- R&D
- Quality
- Regulatory Affairs
- Clinical Development
- Manufacturing
- Commercial Strategy
Sample Reader Organizations
- Pharma product development organizations
- Biotech formulation teams
- Drug-device combination developers
- Commercial product and lifecycle management teams
High-Interest Topics
- Formulation
- Oral Delivery
- Injectables
- Combination Products
- Controlled Release
- Bioavailability
- Device Development
- Patient Experience
- Scale-Up
- Manufacturing
Ways to Engage This Audience
Content and Thought Leadership
Technical articles, white papers, case studies, and sponsored content focused on formulation, delivery technologies, devices, routes of administration, and product performance.
Video and Webinars
Webcasts and video interviews that help development teams evaluate delivery approaches, technologies, and specialized external capabilities.
Targeted Audience Programs
ABM360, interest-based programs, and custom newsletters focused on formulation, delivery, device, development, and target-account audiences.
A specialized community for professionals navigating biosimilar development, analytical similarity, clinical strategy, regulatory pathways, manufacturing, and commercialization.
Biosimilar programs require coordinated scientific, regulatory, clinical, manufacturing, and commercial decisions, often creating demand for experienced external partners across the development lifecycle.
Relevant Reader Roles and Titles
- Biosimilar Development
- Analytical Development
- CMC
- Clinical Development
- Regulatory Affairs
- Manufacturing
- Quality
- Medical Affairs
- Commercial Strategy
- Executive Leadership
Sample Reader Organizations
- Biosimilar developers
- Global pharmaceutical companies building biosimilar portfolios
- Biologics manufacturers entering new markets
- Teams evaluating analytical, regulatory, clinical, and manufacturing partners
High-Interest Topics
- Analytical Similarity
- Regulatory Strategy
- Clinical Development
- Manufacturing
- Interchangeability
- Market Access
- Commercialization
- Global Development
- Quality
- Portfolio Strategy
Ways to Engage This Audience
Content and Thought Leadership
Technical articles, expert Q&As, white papers, case studies, and sponsored content addressing biosimilar development, manufacturing, regulatory strategy, and commercialization.
Video and Webinars
Webcasts and video interviews that help audiences explore analytical, clinical, regulatory, manufacturing, and market considerations.
Targeted Audience Programs
ABM360, interest-based programs, and custom newsletters focused on biosimilar development roles, topics, organizations, and target accounts.
A community for executives and senior leaders navigating the strategic, financial, operational, regulatory, partnership, and growth decisions that shape life science organizations.
Executive leaders influence outsourcing models, capital allocation, network strategy, partnerships, portfolio priorities, and the organizational decisions behind major external investments.
Relevant Reader Roles and Titles
- CEOs
- Founders
- Executive Leadership
- Operations Leaders
- R&D Leadership
- Manufacturing Leaders
- Commercial Leaders
- Finance
- Business Development
- Regulatory Leaders
- Board Advisors
Sample Reader Organizations
- Emerging and growth-stage biotech companies
- Established pharmaceutical organizations
- Investor-backed life science companies
- Organizations navigating funding, partnerships, commercialization, and growth
High-Interest Topics
- Executive Strategy
- Outsourcing Models
- Funding
- Partnerships
- Manufacturing Networks
- Company Building
- Commercialization
- Risk Management
- Portfolio Strategy
- Growth
Ways to Engage This Audience
Executive Content
Executive thought leadership, interviews, white papers, and case studies addressing partnerships, company strategy, operations, investment, and growth.
Video and Multimedia
Video interviews and STREAM programs that give senior leaders a credible platform to share strategic perspective.
Targeted Audience Programs
ABM360, interest-based programs, and sponsored visibility focused on executive, business, operations, and target-account audiences.
OUTSOURCING EXPERIENCES & MARKET INTELLIGENCE
Engage Outsourcing Audiences Beyond the Online Community
Extend visibility and connection through capability-focused digital events, in-person experiences, market intelligence, peer exchange, editorial programming, and research-based recognition.
Capabilities Event
Outsourced Pharma Capabilities Update
Showcase current development and manufacturing capabilities to pharma and biopharma teams actively evaluating available capacity.
- Capability-focused presentations
- Coverage across major outsourcing service categories
- Direct visibility with teams evaluating capacity
In-Person Event
CDMO Live Americas
Connect with North American outsourcing leaders through expert content, curated partner meetings, and focused networking.
- Senior biopharma outsourcing decision-makers
- Curated PartnerMatch meetings
- Outsourcing strategy and peer exchange
In-Person Event
CDMO Live Europe
Engage European biopharma outsourcing leaders through expert content, curated partner meetings, and peer connection.
- European development and manufacturing audience
- Curated partner discovery
- Focused outsourcing conversations
Peer Leadership Network
External Manufacturing Leaders
Connect with senior pharmaceutical professionals working through manufacturing strategy, external partner networks, risk, and resilience.
- Invitation-only senior peer forums
- Confidential strategic discussion
- Shared insight around complex challenges
Market Intelligence Platform
PharmaSource
Extend visibility through market intelligence, partner discovery, reports, podcasts, and practical resources used across the outsourcing ecosystem.
- Outsourcing news and analysis
- Partner discovery and practical resources
- Reports, podcasts, guides, and partner content
Research-Based Recognition
CDMO Leadership Awards
Independent recognition based on verified feedback from biopharma companies with recent outsourcing experience.
- Evaluation based on feedback from CDMO customers
- Independent research methodology
- Recognition grounded in real partnership experience
Editorial Programs and Live Events
Extend Expertise Through Editorial Programming
Connect your experts with biopharma outsourcing and technical audiences through distinct editor-led programs.
Build credibility before the partner shortlist takes shape.
Outsourcing relationships develop over time. Biopharma teams research service categories, compare capabilities, revisit risk, and return to trusted sources as needs become clearer. That creates multiple opportunities to educate, stay visible, and support stronger conversations.
Stage 1
Identify the Right Outsourcing Audience
Focus on modality, service category, company type, geography, development stage, and decision-making role.
Stage 2
Demonstrate Relevant Expertise
Use editorial content, case studies, interviews, webinars, and market insight to educate around real outsourcing challenges.
Stage 3
Create Year-Round Presence
Connect digital visibility with market intelligence, targeted audience programs, podcasts, reports, partner discovery, and live experiences.
Stage 4
Support Better Conversations
Use engagement and event context to help business development teams prioritize accounts and prepare more relevant outreach.
Connect Across the Outsourcing Decision Process
Life Science Connect helps organizations align audience strategy, useful content, sustained visibility, market intelligence, and direct engagement across the outsourcing ecosystem.
- Reach decision-makers and influencers across outsourcing, external manufacturing, CMC, quality, procurement, supply chain, and executive functions
- Contribute expertise tied to partner fit, tech transfer, quality, capacity, resilience, and CDMO performance
- Combine editorial content, newsletters, reports, podcasts, directory visibility, targeted audience programs, and live experiences
- Use digital and event engagement context to support more relevant sales follow-up
Ready to Reach the Right Outsourcing Audiences?
We can help identify the communities, roles, topics, and experiences that create the most relevant path to visibility, engagement, and stronger partner conversations.